北京大学学报（医学版） ›› 2018, Vol. 50 ›› Issue (6): 952-955. doi: 10.19723/j.issn.1671-167X.2018.06.002
自身抗体在肿瘤及感染性疾病发生、发展中的作用
王永福(
),刘媛
- 内蒙古科技大学包头医学院第一附属医院风湿免疫科, 内蒙古自治区包头 014010
中图分类号:
- R593.2
| [1] |
Burnham TK . Antinuclear antibodies in patients with malignancies[J]. Lancet, 1972,2(7774):436.
doi: 10.1016/S0140-6736(72)91842-9 pmid: 4115262 |
| [2] |
Vlagea A, Falagan S, Gutierrez-Gutierrez G , et al. Antinuclear antibodies and cancer: A literature review[J]. Crit Rev Oncol Hematol, 2018,127:42-49.
doi: 10.1016/j.critrevonc.2018.05.002 |
| [3] |
Sahin U, Tureci O, Schmitt H , et al. Human neoplasms elicit multiple specific immune responses in the autologous host[J]. Proc Natl Acad Sci USA, 1995,92(25):11810-11813.
doi: 10.1073/pnas.92.25.11810 pmid: 8524854 |
| [4] |
Dellen H, Seemayer NH . Autoimmunity in patients with bronchogenic carcinomas: occurrence of antibodies against nuclear antigens, chromosomes and ds-deoxyribonucleic acid[J]. Zentralbl Bakteriol Mikrobiol Hyg B, 1983,177(6):451-468.
pmid: 6322478 |
| [5] |
Riska H, Fyhrquist F, Selander RK , et al. Systemic lupus erythematosus and DNA antibodies in pleural effusions[J]. Scand J Rheumatol, 1978,7(3):159-160.
doi: 10.3109/03009747809095646 pmid: 310156 |
| [6] |
Attar SM, Koshak EA . Medical conditions associated with a positive anti-double-stranded deoxyribonucleic acid[J]. Saudi Med J, 2010,31(7):781-787.
doi: 10.5336/medsci.2009-16065 pmid: 20635012 |
| [7] | Cavagna L, Prisco E, Montecucco C , et al. Association between anti-dsDNA titre increase and thymoma relapse[J]. Clin Exp Rheumatol, 2011,29(3):599-600. |
| [8] | 邹和建 . 系统性红斑狼疮与自身抗体[J]. 皮肤科学通报, 2018,35(3):258-264. |
| [9] |
Katz U, Zandman-Goddard G . Drug-induced lupus: an update[J]. Autoimmun Rev, 2010,10(1):46-50.
doi: 10.1016/j.autrev.2010.07.005 pmid: 20656071 |
| [10] |
Kamei M, Kato M, Mochizuki K , et al. Serodiagnosis of cancers by ELISA of anti-histone H2B antibody[J]. Biotherapy, 1992,4(1):17-22.
doi: 10.1007/BF02171705 pmid: 1543647 |
| [11] |
Sakamoto J, Fujiya M, Okamoto K , et al. Immunoprecipitation of nucleosomal DNA is a novel procedure to improve the sensitivity of serum screening for the p16 hypermethylation associated with colon cancer[J]. Cancer Epidemiol, 2010,34(2):194-199.
doi: 10.1016/j.canep.2010.01.004 pmid: 20129840 |
| [12] |
Fragkioudaki S, Mavragani CP, Moutsopoulos HM . Predicting the risk for lymphoma development in Sjögren syndrome: An easy tool for clinical use[J]. Medicine, 2016,95(25):e3766.
doi: 10.1097/MD.0000000000003766 |
| [13] |
Quartuccio L, Baldini C, Bartoloni E , et al. Anti-SSA/SSB-negative Sjögren’s syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution[J]. Autoimmun Rev, 2015,14(11):1019-1022.
doi: 10.1016/j.autrev.2015.07.002 |
| [14] |
Matsuda M , Yamada T. snRNPs from mouse teratocarcinoma cells reacting with polyclonal anti-Sm and anti-m3(2,2,7)G antibodies and bioche-mical characterization of the snRNPs[J]. Nihon Juigaku Zasshi, 1987,49(6):981-987.
doi: 10.1292/jvms1939.49.981 pmid: 2963163 |
| [15] |
Imran A, Neelam F, Tariq M . Incidence of circulating antinuclear antibodies in cancer patients[J]. Indian J Med Sci, 2003,57(3):113-116.
pmid: 14514262 |
| [16] |
Zou HY, Gu X, Yu WZ , et al. Detection of serum antinuclear antibodies in lymphoma patients[J]. Genet Mol Res, 2015,14(4):16546-16552.
doi: 10.4238/2015.December.11.1 pmid: 26681000 |
| [17] |
Fernandez-Madrid F , VandeVord PJ, Yang X, et al. Antinuclear antibodies as potential markers of lung cancer[J]. Clin Cancer Res, 1999,5(6):1393-1400.
doi: 10.1590/S0004-282X1994000300022 pmid: 10389924 |
| [18] |
Syrigos KN, Charalambopoulos A, Pliarchopoulou K , et al. The prognostic significance of autoantibodies against dsDNA in patients with colorectal adenocarcinoma[J]. Anticancer Res, 2000,20(6B):4351-4353.
doi: 10.1097/00001813-200011000-00012 pmid: 11205270 |
| [19] |
Mitchell P, Thatcher N, Socinski MA , et al. Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses[J]. Ann Oncol, 2015,26(6):1134-1142.
doi: 10.1093/annonc/mdv104 pmid: 25722382 |
| [20] |
Maire C, Vercambre-Darras S, Devos P , et al. Metastatic melanoma: spontaneous occurrence of auto antibodies is a good prognosis factor in a prospective cohort[J]. J Eur Acad Dermatol Venereol, 2013,27(1):92-96.
doi: 10.1111/j.1468-3083.2011.04364.x pmid: 22145691 |
| [21] | Altintas A, Cil T, Pasa S , et al. Clinical significance of elevated antinuclear antibody test in patients with Hodgkin’s and non-Hodgkin’s lymphoma: a single center experience[J]. Minerva Med, 2008,99(1):7-14. |
| [22] |
Tan EM . Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology[J]. Adv Immunol, 1989,44:93-151.
doi: 10.1016/S0065-2776(08)60641-0 |
| [23] |
Ringrose JH, Muijsers AO, Pannekoek Y , et al. Influence of infection of cells with bacteria associated with reactive arthritis on the peptide repertoire presented by HLA-B27[J]. J Med Microbiol, 2001,50(4):385-389.
doi: 10.1086/319288 pmid: 11289525 |
| [24] |
Clark SE, Weiser JN . Microbial modulation of host immunity with the small molecule phosphorylcholine[J]. Infect Immun, 2013,81(2):392-401.
doi: 10.1128/IAI.01168-12 pmid: 3553803 |
| [25] |
Flodstrom-Tullberg M . Viral infections: their elusive role in regulating susceptibility to autoimmune disease[J]. Microbes Infect, 2003,5(10):911-921.
doi: 10.1016/S1286-4579(03)00161-8 pmid: 12919859 |
| [26] |
Monsalve DM, Pacheco Y, Acosta-Ampudia Y , et al. Zika virus and autoimmunity. One-step forward[J]. Autoimmun Rev, 2017,16(12):1237-1245.
doi: 10.1016/j.autrev.2017.10.008 pmid: 29037898 |
| [27] |
Sene D, Piette JC, Cacoub P . Antiphospholipid antibodies, antiphospholipid syndrome and infections[J]. Autoimmun Rev, 2008,7(4):272-277.
doi: 10.1016/j.autrev.2007.10.001 pmid: 18295729 |
| [28] |
Tanay A . Chikungunya virus and autoimmunity[J]. Curr Opin Rheumatol, 2017,29(4):389-393.
doi: 10.1097/BOR.0000000000000396 |
| [29] |
Wan SW, Lin CF, Yeh TM , et al. Autoimmunity in dengue pathogenesis[J]. J Formos Med Assoc, 2013,112(1):3-11.
doi: 10.1016/j.jfma.2012.11.006 |
| [30] |
Garzelli C, Pacciardi A, Basolo F , et al. Mechanisms other than polyclonal B cell activation possibly involved in Epstein-Barr virus-induced autoimmunity[J]. Clin Exp Immunol, 1989,76(3):412-416.
doi: 10.1002/chir.22478 pmid: 2546702 |
| [31] |
Kivity S, Agmon-Levin N, Blank M , et al. Infections and autoimmunity: friends or foes?[J]. Trends Immunol, 2009,30(8):409-414.
doi: 10.1016/j.it.2009.05.005 pmid: 19643667 |
| [32] |
Rubtsova K , Rubtsov AV, van Dyk LF, et al. T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance[J]. Proc Natl Acad Sci USA, 2013,110(34):E3216-3224.
doi: 10.1073/pnas.1312348110 pmid: 23922396 |
| [33] |
Yee LJ, Kelleher P, Goldin RD , et al. Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance[J]. J Viral Hepat, 2004,11(5):459-464.
doi: 10.1111/j.1365-2893.2004.00530.x pmid: 15357653 |
| [34] |
Hao Y , O’Neill P, Naradikian MS, et al. A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice[J]. Blood, 2011,118(5):1294-1304.
doi: 10.1182/blood-2011-01-330530 |
| [35] |
Litwin CM, Binder SR . ANA testing in the presence of acute and chronic infections[J]. J Immunoassay Immunochem, 2016,37(5):439-452.
doi: 10.1080/15321819.2016.1174136 pmid: 27050929 |
| [36] |
Shoenfeld Y, Vilner Y, Coates AR , et al. Monoclonal anti-tuberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis[J]. Clin Exp Immunol, 1986,66(2):255-261.
doi: 10.1016/0008-8749(86)90083-3 pmid: 3102132 |
| [37] |
Faaber P, Capel PJ, Rijke GP , et al. Cross-reactivity of anti-DNA antibodies with proteoglycans[J]. Clin Exp Immunol, 1984,55(3):502-508.
pmid: 6608423 |
| [1] | 李君,刘旭红,王工,程程,庄洪卿,杨瑞杰. 手臂位置对射波刀放射治疗脊柱肿瘤患者的剂量学影响[J]. 北京大学学报（医学版）, 2022, 54(1): 182-186. |
| [2] | 杨朵,周心娜,王硕,王小利,袁艳华,杨化兵,耿会珍,彭兵,李子博,李彬,任军. 树突状细胞疫苗特异肿瘤多肽联合树突状细胞体外刺激淋巴细胞功能评估[J]. 北京大学学报（医学版）, 2021, 53(6): 1094-1098. |
| [3] | 肖云抒,朱冯赟智,罗澜,邢晓燕,李玉慧,张学武,沈丹华. 88例重叠肌炎的临床及免疫学特征[J]. 北京大学学报（医学版）, 2021, 53(6): 1088-1093. |
| [4] | 娄雪,廖莉,李兴珺,王楠,刘爽,崔若玫,徐健. 类风湿关节炎患者外周血TWEAK基因启动子区甲基化状态及其表达[J]. 北京大学学报（医学版）, 2021, 53(6): 1020-1025. |
| [5] | 罗澜,邢晓燕,肖云抒,陈珂彦,朱冯赟智,张学武,李玉慧. 抗合成酶综合征合并心脏受累患者的临床及免疫学特征[J]. 北京大学学报（医学版）, 2021, 53(6): 1078-1082. |
| [6] | 牛占岳,薛艳,张静,张贺军,丁士刚. 胃腺瘤性息肉的内镜和病理特点及癌变的危险因素分析[J]. 北京大学学报（医学版）, 2021, 53(6): 1122-1127. |
| [7] | 叶剑飞,赵磊,王国良,洪锴,马潞林. 睾丸横纹肌肉瘤的诊治分析[J]. 北京大学学报（医学版）, 2021, 53(6): 1178-1182. |
| [8] | 田雨,程晓悦,贺慧颖,王国良,马潞林. 肾细胞癌合并尿路瘤栓的临床病理特征: 6例报道及文献回顾[J]. 北京大学学报（医学版）, 2021, 53(5): 928-932. |
| [9] | 庞泳,张沙,杨华,周柔丽. LAPTM4B-35蛋白作为肝癌血清学诊断新标志物的探讨[J]. 北京大学学报（医学版）, 2021, 53(4): 710-715. |
| [10] | 孙争辉,黄晓娟,董靖晗,刘茁,颜野,刘承,马潞林. 临床T1期肾细胞癌肾窦侵犯的危险因素[J]. 北京大学学报（医学版）, 2021, 53(4): 659-664. |
| [11] | 康文玉,王璐,邱敏,张帆,郭巍,强亚勇,拓鹏飞,宗有龙,刘磊磊,王帅帅. 肾上腺海绵状血管瘤1例及文献回顾[J]. 北京大学学报（医学版）, 2021, 53(4): 808-810. |
| [12] | 林国中, 马长城, 王振宇, 谢京城, 刘彬, 陈晓东. 颈1~2硬膜外神经鞘瘤的显微微创治疗[J]. 北京大学学报（医学版）, 2021, 53(3): 586-589. |
| [13] | 杨榕,李庆祥,王逸飞,周闻,王雯,郭传瑸,刘浩,郭玉兴. 碘液浸染在Micro-CT下识别小鼠颅底-颞下区肿瘤组织中的应用[J]. 北京大学学报（医学版）, 2021, 53(3): 598-601. |
| [14] | 李新飞, 彭意吉, 余霄腾, 熊盛炜, 程嗣达, 丁光璞, 杨昆霖, 唐琦, 米悦, 吴静云, 张鹏, 谢家馨, 郝瀚, 王鹤, 邱建星, 杨建, 李学松, 周利群. 肾部分切除术前CT三维可视化评估标准的初步探究[J]. 北京大学学报（医学版）, 2021, 53(3): 613-622. |
| [15] | 周川, 马雪, 邢云昆, 李璐迪, 陈洁, 姚碧云, 傅娟玲, 赵鹏. 基于肿瘤基因组图谱数据库探索性筛选潜在泛癌生物标志物[J]. 北京大学学报（医学版）, 2021, 53(3): 602-607. |
|
